Release Date: 30/04/18 17:20 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 1.04MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%